Organigram Hlds's average rating is Hold from 12 analysts. Do analysts base this consensus on technical analyses? We know that typical technical analysis utilizes price momentum, patterns, and trends looking at historical prices. It aims to identify signals based on Organigram Hlds market sentiment investors' perception of the future value of Organigram. Let us look at a few aspects of Organigram technical analysis.
Using predictive
technical analysis, we can analyze different prices and returns patterns and
diagnose historical swings to determine the real value of OrganiGram Holdings. In general, sophisticated investors focus on analyzing OrganiGram Holdings stock price patterns and their correlations with different microeconomic environment and drivers. They apply predictive analytics to build OrganiGram Holdings's daily price indicators and compare them against related drivers such as
momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional
technical analysis and
fundamental analysis, we attempt to find the most accurate representation of OrganiGram Holdings's intrinsic value. In addition to deriving basic predictive indicators for OrganiGram Holdings, many experienced traders also check how macroeconomic factors affect OrganiGram Holdings price patterns. Please read more on our
technical analysis page or use our predictive modules below to complement your research.
Sophisticated investors, who have witnessed
many market ups and downs, anticipate that the market will even out over time. This tendency of OrganiGram Holdings' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as OrganiGram Holdings. Your research has to be compared to or analyzed against OrganiGram Holdings' peers to derive any actionable benefits. When done correctly, OrganiGram Holdings' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in OrganiGram Holdings.
How important is OrganiGram Holdings's Liquidity
OrganiGram Holdings
financial leverage refers to using borrowed capital as a funding source to finance OrganiGram Holdings ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. OrganiGram Holdings financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to OrganiGram Holdings' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of OrganiGram Holdings' financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the
breakdown between OrganiGram Holdings's total debt and its cash.
OrganiGram Holdings Gross Profit
OrganiGram Holdings Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing OrganiGram Holdings previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show OrganiGram Holdings Gross Profit growth over the last 10 years. Please check OrganiGram Holdings'
gross profit and other
fundamental indicators for more details.
Closer look at Organigram Hlds Semi Deviation
Organigram Hlds has current Semi Deviation of 4.73. Semi-deviation provides a good measure of downside risk for a equity or a portfolio. It is similar to standard deviation, but it only looks at periods where the returns are less than the target or average level.
Semi-deviation is the square root of semi-variance. Semi-variance is calculated by averaging the deviations of returns that have a result that is less than the mean.
Semi Deviation | = | SQRT(SV) |
| = | 4.73 |
Let's now compare Organigram Hlds Semi Deviation to its closest peers:
| OGI | 4.734223721863008 |
| BHC | 2.38 |
| ELAN | 2.25 |
| ENDP | 3.24 |
| ACB | 7.39 |
Our take on today Organigram Hlds rise
The downside variance is down to 31.23 as of today. Organigram Hlds exhibits above-average semi-deviation for your current time horizon. We encourage investors to investigate Organigram Hlds individually to make sure intended market timing strategies and available technical indicagtors are consistent with their estimates about Organigram Hlds future systematic risk.
Our Final Take On Organigram Hlds
While other companies within the drug manufacturers—specialty & generic industry are still a little expensive, even after the recent corrections, Organigram Hlds may offer a potential longer-term growth to stockholders. To conclude, as of the 29th of November 2020, our final 30 days buy-or-sell advice on the company is
Strong Sell. However, we believe Organigram Hlds is
undervalued with
below average probability of distress for the next two years.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Vlad Skutelnik is a Macroaxis Contributor. Vlad covers stocks, funds, cryptocurrencies, and ETFs that are traded in North America, focusing primarily on fundamentals, valuation and market volatility. He has many years of experience in fintech, predictive investment analytics, and risk management.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of OrganiGram Holdings. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com